XTuit Pharmaceuticals, Inc., was founded in 2011 by Harvard Professor Rakesh Jain, MIT Professor Bob Langer, and Polaris partner Alan Crane. The company is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment.